Biotech

Vnzymes: European Subsidiary of VTR Biotech Opens New Office in Frankfurt

Vnzymes, the subsidiary of VTR Biotech Group, has officially opened its new office in Frankfurt, expanding its presence in Europe.
Image provided by Vnzymes.

Key Takeaways

  • Vnzymes has officially opened its new office in Frankfurt, expanding its presence in Europe.
  • The subsidiary will support regional R&D, technical services, and market development.
  • Leadership emphasized the company’s mission to address sustainability and efficiency in animal nutrition and agriculture.
  • The new hub strengthens VTR Biotech’s global network spanning more than 60 countries.
  • Vnzymes highlighted its enzyme and natural additive portfolio designed to improve livestock performance and health.

Vnzymes Expands Operations with New European Hub

Vnzymes, the newly launched brand and European subsidiary of VTR Biotech Group, has formally opened its office in Frankfurt, marking a significant development in the company’s global expansion strategy. The new location reinforces the company’s commitment to advancing innovation in animal nutrition, industrial enzymes, and sustainable agriculture across Europe.


Strengthens Regional Presence with Dedicated Facility

Built on the backing of VTR Biotech’s extensive scientific expertise, Vnzymes will utilize its Frankfurt office as the central base for its European activities. The space will support research and development, technical service delivery, and localized market development tailored to European industry needs.

“For more than 30 years, VTR Biotech has been dedicated to its mission of ‘Bioscience Impact Tomorrow’, advancing the research, development, and application of enzyme preparations, biosynthetic products, and plant extracts,” said Cindy Chen, CEO of Vnzymes. “With the launch of Vnzymes in Europe, we are creating a platform that not only leverages our global expertise but also addresses local market requirements in animal nutrition and health.”


Vnzymes Highlights Innovation and Global Collaboration

Starting in Asia, VTR Biotech has expanded its global sales network to more than 60 countries. The establishment of the European subsidiary marks a strategic move to accelerate innovation in animal nutrition, bio-agriculture, and plant extract technologies. The company aims to deliver biosolutions focused on sustainability, efficiency, and responsible production.

“As the global market evolves, true globalization is about more than expanding into new territories,” said Dr. Wang Yufeng, Senior Technical Director at Vnzymes. “It’s about delivering meaningful innovations that meet local needs while maintaining a global perspective.”


Showcases Enzyme and Natural Additive Portfolio

The company’s product lineup features key enzyme solutions, including xylanase and phytase, aimed at enhancing nutrient digestibility and supporting intestinal health in livestock. Vnzymes also offers natural feed additives derived from Macleaya cordata, known to strengthen immunity, improve antioxidant capacity, and support sustainable animal production.

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply